David J. King
2017
In 2017, David J. King earned a total compensation of $549.4K as Chief Scientific Officer at aTYR PHARMA.
Compensation breakdown
| Non-Equity Incentive Plan | $68,250 |
|---|---|
| Option Awards | $173,979 |
| Salary | $300,000 |
| Other | $7,130 |
| Total | $549,359 |
King received $300K in salary, accounting for 55% of the total pay in 2017.
King also received $68.3K in non-equity incentive plan, $174K in option awards and $7.1K in other compensation.
Rankings
In 2017, David J. King's compensation ranked 11,505th out of 14,666 executives tracked by ExecPay. In other words, King earned more than 21.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,505 out of 14,666 | 22nd |
Division Manufacturing | 4,510 out of 5,772 | 22nd |
Major group Chemicals And Allied Products | 1,646 out of 2,075 | 21st |
Industry group Drugs | 1,361 out of 1,731 | 21st |
Industry Biological Products, Except Diagnostic Substances | 242 out of 313 | 23rd |
Source: SEC filing on April 3, 2018.
King's colleagues
We found three more compensation records of executives who worked with David J. King at aTYR PHARMA in 2017.